• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Safinamide

CAS No. 133865-89-1

Safinamide ( EMD-1195686 | FCE-26743 )

产品货号. M11361 CAS No. 133865-89-1

一种有效的选择性 MAO-B 抑制剂,IC50 为 98 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥316 有现货
10MG ¥437 有现货
25MG ¥745 有现货
50MG ¥1110 有现货
100MG ¥1596 有现货
500MG ¥4155 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Safinamide
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    一种有效的选择性 MAO-B 抑制剂,IC50 为 98 nM。
  • 产品描述
    A potent and selective inhibitor of MAO-B with IC50 of 98 nM; displays >5,000-fold selectivity over MAO-A; also inhibits glutamate release and dopamine reuptake, inhibits voltage-dependent Na+ and Ca2+ channels; is used for treatment ofParkinson's disease.Parkinson's Disease Approved.
  • 体外实验
    Safinamide (1–300?μM) reduces the amplitude of the peak sodium currents in a concentration-dependent manner.?When currents are stimulated to a?Vtest?of +10 mV from a?Vh?of -110 mV, the IC50?value was 262?μM. When the holding potential is depolarized to -53 mV, the inhibitory effect of safinamide with a lower IC50?value (8?μM) in rat cortical neurons.
  • 体内实验
    Safinamide (intraperitoneal?injection; 90 mg/kg; once daily; 14 days) treatment prior to MCAO significantly ameliorates MCAO-caused cerebral infarction volume, neurological deficit, disruption of the brain-blood barrier (BBB), and impairs expression of tight junction protein occludin and ZO-1 in mice.Safinamide (intraperitoneal?injection; 5 mg/kg, 15 mg/kg and 30 mg/kg) dose dependently inhibits the veratridine-induced GABA release and Glu release in vivo. At the dose 30 mg/kg, ?Safinamide prevents the effect of veratridine both on Glu (treatment?F1,8=1.31; time×treatment interaction?F8,64=2.4) and GABA (treatment?F1,8=4.04; time?F8,64=3.76, time×treatment interaction?F8,64?= 2.83) release.Safinamide causes a slight, albeit not significant, reduction of veratridine-stimulated Glu release at 0.5 mg/kg and full inhibition at 5 and 15 mg/kg in rat. Animal Model:Focal cerebral ischemia C57/BL6 male mouse ModelDosage:90 mg/kg Administration:Intraperitoneal?injection; once daily; 14 days Result:Significantly decreased infarction volume in brain areas.
  • 同义词
    EMD-1195686 | FCE-26743
  • 通路
    Metabolic Enzyme/Protease
  • 靶点
    MAO
  • 受体
    MAO
  • 研究领域
    Neurological Disease
  • 适应症
    Parkinson Disease

化学信息

  • CAS Number
    133865-89-1
  • 分子量
    302.3434
  • 分子式
    C17H19FN2O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    10 mM in DMSO
  • SMILES
    CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F
  • 化学全称
    Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2S)-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Leonetti F, et al. J Med Chem. 2007 Oct 4;50(20):4909-16. 2. Strolin Benedetti MS, et al. J Pharm Pharmacol. 1994 Oct;46(10):814-9. 3. Caccia C, et al. Neurology. 2006 Oct 10;67(7 Suppl 2):S18-23.
产品手册
关联产品
  • Esuprone

    Esuprone (LU-43839) is a novel reversible and highly selective MAO-A inhibitor with anticonvulsant activity for the treatment of depression.

  • Paeonol

    丹皮酚 (Peonol) 是从中药牡丹皮和徐长卿中提取的酚类化合物,可抑制 MAO,IC50 约为 50 μM。

  • CX-157

    CX-157 是一个可逆的单胺氧化酶-A (MAO-A) 抑制剂,其 EC50 值为 19.3 ng/mL。